China Shineway Pharmaceutical Group Limited
CSWYY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | – | $2 |
| % Growth | -3.3% | – | – | – |
| Cost of Goods Sold | $0 | $0 | – | $1 |
| Gross Profit | $0 | $0 | – | $2 |
| % Margin | 72.2% | 74.5% | – | 75.1% |
| R&D Expenses | $0 | $0 | – | $0 |
| G&A Expenses | $0 | $0 | – | $0 |
| SG&A Expenses | $0 | $0 | – | $1 |
| Sales & Mktg Exp. | $0 | $0 | – | $1 |
| Other Operating Expenses | $0 | $0 | – | $0 |
| Operating Expenses | $0 | $0 | – | $1 |
| Operating Income | $0 | $0 | – | $0 |
| % Margin | 22.4% | 16.3% | – | 18.1% |
| Other Income/Exp. Net | $0 | $0 | – | $0 |
| Pre-Tax Income | $0 | $0 | – | $1 |
| Tax Expense | $0 | $0 | – | $0 |
| Net Income | $0 | $0 | – | $0 |
| % Margin | 37.2% | 12.6% | – | 22.6% |
| EPS | 44.8 | 15.8 | – | 252 |
| % Growth | 183.5% | – | – | – |
| EPS Diluted | 44.8 | 15.8 | – | 253.2 |
| Weighted Avg Shares Out | 0 | 0 | – | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | – | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | – | $0 |
| Interest Expense | $0 | $0 | – | $0 |
| Depreciation & Amortization | $0 | $0 | – | $0 |
| EBITDA | $0 | $0 | – | $0 |
| % Margin | 51.7% | 21.3% | – | 21.9% |